Literature DB >> 30155765

A non-resolving skin lesion in hemodialysis patient: Answers.

Shimrit Tzvi-Behr1, Efrat Ben-Shalom2, Rachel Becker-Cohen2, Graciela Lijozetzky3, Jenny Weinbrand-Goichberg2, Yaacov Frishberg2, Choni Rinat2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30155765     DOI： 10.1007/s00467-018-4066-4

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  6 in total

1.  Oxalate elimination via hemodialysis or peritoneal dialysis in children with chronic renal failure.

Authors:  B Hoppe; D Graf; G Offner; K Latta; D J Byrd; D Michalk; J Brodehl
Journal:  Pediatr Nephrol       Date:  1996-08       Impact factor: 3.714

2.  Transplantation outcomes in primary hyperoxaluria.

Authors:  E J Bergstralh; C G Monico; J C Lieske; R M Herges; C B Langman; B Hoppe; D S Milliner
Journal:  Am J Transplant       Date:  2010-09-17       Impact factor: 8.086

3.  Genotype-phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome.

Authors:  Jérôme Harambat; Sonia Fargue; Cécile Acquaviva; Marie-France Gagnadoux; Françoise Janssen; Aurélia Liutkus; Chebl Mourani; Marie-Alice Macher; Daniel Abramowicz; Christophe Legendre; Antoine Durrbach; Michel Tsimaratos; Hubert Nivet; Eric Girardin; Anne-Marie Schott; Marie-Odile Rolland; Pierre Cochat
Journal:  Kidney Int       Date:  2009-12-16       Impact factor: 10.612

4.  Multiple mechanisms of action of pyridoxine in primary hyperoxaluria type 1.

Authors:  Sonia Fargue; Gill Rumsby; Christopher J Danpure
Journal:  Biochim Biophys Acta       Date:  2013-04-15

Review 5.  The primary hyperoxalurias.

Authors:  Bernd Hoppe; Bodo B Beck; Dawn S Milliner
Journal:  Kidney Int       Date:  2009-02-18       Impact factor: 10.612

Review 6.  Advances in the enzymology and molecular genetics of primary hyperoxaluria type 1. Prospects for gene therapy.

Authors:  C J Danpure
Journal:  Nephrol Dial Transplant       Date:  1995       Impact factor: 5.992
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.